We are live on ! Find out more
VCP

Verus Capital Partners Portfolio holdings

AUM $1.46B
1-Year Est. Return 27.29%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+27.29%
3 Year Est. Return
+82.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$306M
AUM Growth
–
Cap. Flow
+$279M
Cap. Flow %
91.4%
Top 10 Hldgs %
30.8%
Holding
1,601
New
1,342
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.8M
2
NOC icon
Northrop Grumman
NOC
+$11.5M
3
T icon
AT&T
T
+$7.19M
4
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$7M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.96M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Industrials 6.53%
3 Communication Services 5.84%
4 Healthcare 5.35%
5 Financials 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZA
1251
DELISTED
REINSURANCE GROUP OF AMERICA, INCORPORATED 6.20% Fixed-To-Floating Rate Subordinated Debentures due 2042
RZA
$1K ﹤0.01%
+45
New +$1.24K
TRLV
1252
Trulieve Cannabis Corp
TRLV
$1.68B
$1K ﹤0.01%
+125
New +$1K
AOA icon
1253
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.26B
$0 ﹤0.01%
+6
New +$338
ASIX icon
1254
AdvanSix
ASIX
$548M
$0 ﹤0.01%
+6
New +$131
AYTU icon
1255
AYTU BioPharma
AYTU
$24.3M
– –
0
– –
BLUE
1256
DELISTED
bluebird bio
BLUE
– –
0
– –
CVM icon
1257
CEL-SCI Corp
CVM
$26.6M
– –
0
– –
CHRN
1258
ChronoScale Holdings
CHRN
$3.21B
$0 ﹤0.01%
+2
New +$248
EPM icon
1259
Evolution Petroleum
EPM
$128M
$0 ﹤0.01%
+61
New +$336
FCVT icon
1260
First Trust SSI Strategic Convertible Securities ETF
FCVT
$101M
$0 ﹤0.01%
+10
New +$321
GGZ
1261
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$127M
$0 ﹤0.01%
+20
New +$226
GTX icon
1262
Garrett Motion
GTX
$5.77B
$0 ﹤0.01%
+47
New +$479
KNDI
1263
Kandi Technologies Group
KNDI
$67.3M
$0 ﹤0.01%
+95
New +$463
KOSS icon
1264
Koss Corp
KOSS
$35.3M
$0 ﹤0.01%
+260
New +$443
LCTX icon
1265
Lineage Cell Therapeutics
LCTX
$284M
$0 ﹤0.01%
+2
New +$2
NIO icon
1266
NIO
NIO
$11.5B
$0 ﹤0.01%
+70
New +$141
ONCY
1267
Oncolytics Biotech
ONCY
$95.8M
$0 ﹤0.01%
+52
New +$59
PALI icon
1268
Palisade Bio
PALI
$361M
– –
0
– –
PMF
1269
DELISTED
PIMCO Municipal Income Fund
PMF
$0 ﹤0.01%
+25
New +$380
PRTA icon
1270
Prothena Corp
PRTA
$439M
$0 ﹤0.01%
+3
New +$32
PTON icon
1271
Peloton Interactive
PTON
$2.43B
$0 ﹤0.01%
+10
New +$269
RIOT icon
1272
Riot Platforms
RIOT
$8.21B
$0 ﹤0.01%
+50
New +$75
SPB icon
1273
Spectrum Brands
SPB
$2.07B
$0 ﹤0.01%
+3
New +$170
WVE icon
1274
Wave Life Sciences
WVE
$1.19B
$0 ﹤0.01%
+40
New +$981
ABTC
1275
American Bitcoin Corp
ABTC
$447M
– –
0
– –
48 49 50
51
52

Similar funds

ACM
Adelante Capital Management Alameda, California $1.46B AUM 8.98% 1-Year Est. Return
LLL
Lynrock Lake LP Rye Brook, New York $1.46B AUM 17.55% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
SVWAG
Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return
L7C
Liberty 77 Capital Washington, District of Columbia $1.46B AUM 33.32% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
HTI
Hikari Tsushin Inc Tokyo, Japan $1.45B AUM 3.37% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

Verus Capital Partners's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Verus Capital Partners, which disclosed 1,601 positions worth $306M. Its ten largest holdings account for 31% of the portfolio.

Its largest position is Apple: 447,028 shares worth $32.8M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Industrials and Communication Services.

  • Verus Capital Partners's largest Q4 2019 buy was Apple: 447,028 shares worth $32.8M.
  • Verus Capital Partners's ten largest holdings make up 31% of its $306M portfolio in Q4 2019.
  • Verus Capital Partners disclosed 1,601 positions in Q4 2019, its first 13F filing on record.

Based on Verus Capital Partners's 13F filing for Q4 2019, filed 27 Feb 2020.